Join our email list to stay up to date on the latest Amyloidosis news.
Potential Pathways for Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis
Join us for this hybrid in-person and virtual meeting of the Amyloidosis Forum that will explore the different imaging modalities currently being used in AL/ATTR amyloidosis.
The discussion will seek to identify knowledge gaps impeding their implementation as validated tools that can serve as endpoints adequate for drug approval in interventional clinical trials.
This meeting is open to the public, with discussion intended for researchers, clinicians, regulators, patient representatives, and industry.